NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
21 hedge funds and large institutions have $301K invested in NeuBase Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 7 closing their positions.
Holders
21
Holders Change
-6
Holders Change %
-22.22%
% of All Funds
0.33%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
4
Reduced
3
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
TSS
1
Two Sigma Securities
New York
|
$10.7K |
2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$13.5K |
3 |
3
Wells Fargo
San Francisco,
California
|
$56 |
4 |
4
Morgan Stanley
New York
|
$8 |